Fitaro 0.5mg Injection is used to manage type 2 diabetes mellitus.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Semaglutide is a medication with multiple formulations, including Wegovy, Ozempic, and Rybelsus. It serves different purposes for specific patient groups:
Avoid alcohol intake since it may worsen the side effects like lactic acidosis and increase the risk of developing low blood sugar levels.
Semaglutide is not recommended during pregnancy, as it is unknown if it affects your unborn baby. Please discuss this with your doctor if you have any concerns regarding this.
Semaglutide should not be used if you are breastfeeding because it is unknown whether it goes into breast milk. Please discuss this with your doctor if you have any concerns regarding this.
Caution should be exercised. If your blood sugar is too low or too high, your driving ability may be affected. Do not drive if these symptoms appear.
Caution should be exercised in people with kidney impairment while using Semaglutide. Inform your doctor before receiving the Fitaro 0.5mg Injection if you have had a kidney impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.
Limited information was available on the use of Semaglutide in patients suffering from liver impairment. Please consult your doctor if you have any concerns regarding using Semaglutide in patients with liver impairment. Your doctor will prescribe only if the benefits outweigh the risks.
Used for weight loss in specific patients.
Fitaro 0.5mg Injection contains semaglutide. Semaglutide is a GLP-1 hormone that enhances glycemic control through various mechanisms, including insulin secretion, slowing gastric emptying, and decreasing postprandial glucagon secretion. This drug is frequently paired with dietary and exercise changes. Altogether Fitaro 0.5mg Injection reduces sugar levels in the body.
Semaglutide is used to treat adults (aged 18 years and older) with type 2 diabetes when diet and exercise are not enough to control blood sugar levels.
This medication is a glucagon-like peptide-1 (GLP-1) agonist. GLP-1 enhances glucose-dependent insulin secretion by pancreatic beta-cells, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying.
Adult Dose:
Child Dose:
Renal Dose:
Limited pregnancy data are available. Animal studies suggest potential fetal risks. The use of semaglutide during pregnancy should only be considered if the potential benefits outweigh the potential risks. Discontinue treatment at least 2 months before planned pregnancy due to the long washout period for semaglutide.
There is no data on the presence of semaglutide in human milk, its effects on breastfed infants, or its impact on milk production. In lactating rats, semaglutide was detected in milk at lower levels compared to maternal plasma.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.